May 20, 2021 -- Artificial intelligence (AI) developer Tempus announced the launch of Lens, a cloud-based data and analytics platform.
The Lens platform is designed to provide scientists and researchers across biotechnology and pharmaceutical companies with short-term, on-demand access to more than 35 petabytes of de-identified clinical and molecular datasets. The platform includes AI analytical tools intended to accelerate drug discovery and development.
The platform enables users to access, analyze, and build upon Tempus' library of data in an optimized environment equipped with the tools needed to extract insights in minutes, the company stated in a release.